Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 19:57
Indivior Pharmaceuticals 1 Year Total Returns (Daily) : 53.31% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 53.31% |
| August 20, 2026 | 56.44% |
| August 19, 2026 | 66.27% |
| August 18, 2026 | 68.36% |
| August 17, 2026 | 66.58% |
| August 14, 2026 | 68.36% |
| August 13, 2026 | 66.39% |
| August 12, 2026 | 69.57% |
| August 11, 2026 | 72.41% |
| August 10, 2026 | 74.86% |
| August 07, 2026 | 76.05% |
| August 06, 2026 | 75.77% |
| August 05, 2026 | 77.66% |
| August 04, 2026 | 72.01% |
| August 03, 2026 | 77.53% |
| July 31, 2026 | 98.07% |
| July 30, 2026 | 131.1% |
| July 29, 2026 | 132.1% |
| July 28, 2026 | 139.8% |
| July 27, 2026 | 133.5% |
| July 24, 2026 | 141.1% |
| July 23, 2026 | 139.0% |
| July 22, 2026 | 150.0% |
| July 21, 2026 | 159.3% |
| July 20, 2026 | 144.3% |
| Date | Value |
|---|---|
| July 17, 2026 | 150.9% |
| July 16, 2026 | 160.2% |
| July 15, 2026 | 166.1% |
| July 14, 2026 | 157.6% |
| July 13, 2026 | 159.9% |
| July 10, 2026 | 163.5% |
| July 09, 2026 | 172.8% |
| July 08, 2026 | 169.5% |
| July 07, 2026 | 162.6% |
| July 06, 2026 | 159.5% |
| July 02, 2026 | 158.4% |
| July 01, 2026 | 174.6% |
| June 30, 2026 | 178.4% |
| June 29, 2026 | 195.8% |
| June 26, 2026 | 205.6% |
| June 25, 2026 | 200.7% |
| June 24, 2026 | 197.9% |
| June 23, 2026 | 186.5% |
| June 22, 2026 | 173.5% |
| June 18, 2026 | 175.5% |
| June 17, 2026 | 175.5% |
| June 16, 2026 | 168.1% |
| June 15, 2026 | 176.5% |
| June 12, 2026 | 176.2% |
| June 11, 2026 | 179.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Supernus Pharmaceuticals, Inc. | 5.84% |
| Liquidia Corp. | 151.4% |
| Corcept Therapeutics, Inc. | 72.23% |
| Amneal Pharmaceuticals, Inc. | 87.93% |
| Prestige Consumer Healthcare, Inc. | -21.60% |